Abstract 1679: APG-2449, a novel focal adhesion kinase (FAK) inhibitor, enhances the antitumor activity of chemotherapy in preclinical models of small-cell lung cancer (SCLC) with activated FAK
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Zhou Yu, Zhiyan Liang, Xinyi Yao, Daojie Liu, Dajun Yang, Yifan Zhai
Institution: Ascentage Pharma Group Inc. (United States)
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409643082